Masterclass: Insights into 2024: The Future of Digital Therapeutics

What does the future hold for digital therapeutics (DTx) in 2024? holds. The past year has taught the industry that the marketplace for digital therapeutics, especially those requiring a prescription, remains precarious. 

Two additional key themes drive much of the conversation on DTx, namely, the importance of securing innovative funding sources that protect project/pipeline integrity, and the power of collaborative partnerships between healthcare providers and DTx companies to drive adoption of integrated solutions. 

Join this masterclass to learn what experts predict for the near-term future of DTx. More specifically, we will discuss:  

• Funding: Alternative funding models to overcome funding challenges. 
• Market shaping: How to establish collaborative partnerships with healthcare providers and other key stakeholders to incentive adoption and integrate DTx into existing healthcare systems 
• Reimbursement: how learnings from 2023 can inform future approaches to reimbursement. 
• Leveraging data-driven insights to demonstrate the effectiveness and value of DTx in improving patient outcomes. 

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.